|
|
Jake A. Kushner, Jing Ye, Markus Schubert, Deborah J. Burks, Matthew A. Dow, Carrie L. Flint, Sanjoy Dutta, Christopher V.E. Wright, Marc R. Montminy, Morris F. White
J Clin Invest. 2002;
109(9):1193
doi:10.1172/JCI14439
Abstract |
Full text
| PDF

T
he homeodomain transcription factor Pdx1 is required for pancreas development, including the differentiation and function of β cells. Mutations in Pdx1 or upstream hepatocyte nuclear factors cause autosomal forms of early-onset diabetes (maturity-onset diabetes of the young [MODY]). In mice, the Irs2 branch of the insulin/Igf signaling system mediates peripheral insulin action and pancreatic β cell growth and function. To investigate whether β cell failure in Irs2–/– mice might be related to dysfunction of MODY-related transcription factors, we measured the expression of Pdx1 in islets from young Irs2–/– mice. Before the onset of diabetes, Pdx1 was reduced in islets from Irs2–/– mice, whereas it was expressed normally in islets from wild-type or Irs1–/– mice, which do not develop diabetes. Whereas male Irs2–/–Pdx1+/+ mice developed diabetes between 8 and 10 weeks of age, haploinsufficiency for Pdx1 caused diabetes in newborn Irs2–/– mice. By contrast, transgenic expression of Pdx1 restored β cell mass and function in Irs2–/– mice and promoted glucose tolerance throughout life, as these mice survived for at least 20 months without diabetes. Our results suggest that dysregulation of Pdx1 might represent a common link between ordinary type 2 diabetes and MODY.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Deletion of the Men1 Gene Prevents Streptozotocin-Induced Hyperglycemia in Mice
Yuqing Yang, Haoren Wang, Xianxin Hua
|
Experimental Diabetes Research
|
2010 |
Pancreatic duodenal homeobox 1 protein is a novel β-cell-specific autoantigen for type I diabetes
Shi-Wu Li, Vijay Koya, Yi Li, William Donelan, Peng Lin, Westley H Reeves, Li-Jun Yang
|
Lab Invest
|
2009 |
The role of FoxO in the regulation of metabolism
D N Gross, A P J van den Heuvel, M J Birnbaum
|
Oncogene
|
2008 |
Insulin Signaling in the Pancreatic β-Cell
Ingo B. Leibiger, Barbara Leibiger, Per-Olof Berggren
|
Annu. Rev. Nutr.
|
2008 |
Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
Akiko Taguchi, Morris F. White
|
Annu. Rev. Physiol.
|
2008 |
Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice
J. Cantley, A. I. Choudhury, H. Asare-Anane, C. Selman, S. Lingard, H. Heffron, P. Herrera, S. J. Persaud, D. J. Withers
|
Diabetologia
|
2007 |
Recovery from diabetes in mice by β cell regeneration
Tomer Nir, Douglas A. Melton, Yuval Dor
|
J. Clin. Invest.
|
2007 |
Regulating insulin signaling and β -cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference.
Morris F. White
|
Can. J. Physiol. Pharmacol.
|
2006 |
Intrinsic Regulators of Pancreatic β-Cell Proliferation
Jeremy J. Heit, Satyajit K. Karnik, Seung K. Kim
|
Annu. Rev. Cell Dev. Biol.
|
2006 |
Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells
H. Wang, M. Iezzi, S. Theander, P. A. Antinozzi, B. R. Gauthier, P. A. Halban, C. B. Wollheim
|
Diabetologia
|
2005 |
|